Results 51 to 60 of about 82,538 (246)
Estimation of Anti -erythropoietin Antibody in Children Receiving Erythropoietin Therapy on Haemodialysis [PDF]
Zagazig University Medical JournalAnaemia affects many haemodialysis patients for a variety of causes. After treatment, anaemia may still occur due to several causes, such as iron deficiency, elevated urea, poor diet, folate and vitamin B deficiencies, and an ineffective dosage of ...
Marwa Ateya +5 more
doaj +1 more source
A Pooled CRISPR Screen Reveals Genes Critical for Erythroblast Enucleation
American Journal of Hematology, EarlyView.ABSTRACT Terminal erythroid differentiation involves dramatic cellular remodeling that culminates in the expulsion of the nucleus, a process known as enucleation. While enucleation is conserved across mammals and is crucial for the generation of fully functional erythrocytes, the mechanisms governing this process have remained largely unknown, in part ...
Marilou Tetard +7 more
wiley +1 more source
Inhibition of gentamicin–induced renal tubular cell necrosis [PDF]
Journal of Nephropathology, 2012 Gentamicin nephrotoxicity limit its usage against gram negative bacteria. Most researches showed that antioxidant agents improved gentamicin nephrotoxicity.
Majid Tavafi
doaj +1 more source
Antierythropoietin Antibodies in Hemodialysis Patients Treated with Recombinant Erythropoietin
Turkish Journal of Nephrology, 2019 OBJECTIVE: Erythropoietin resistance is a serious problem in patients treated with recombinant erythropoietin. Antierythropoietin antibodies are considered to be one of the causes of this resistance.
Savaş ÖZTÜRK +6 more
doaj
Influence of hemoglobin level and dose of administered recombinant human beta erythropoietin on survival of hemodialysis patients [PDF]
Vojnosanitetski Pregled, 2011 Background/Aim. In patients with end-stage renal disease, treatment with erythropoietin lowers cardiovascular morbidity, improves quality of life and patient survival.
Knežević Violeta +5 more
doaj +1 more source
Erythropoietin in Familial Amyloidosis ATTR V30M
, 2013 Familial amyloidosis ATTR V30M is an hereditary disorder, the most frequent type of transthyretin related amyloidosis. The main manifestation of the disease is a sensory-motor and autonomic polyneuropathy.
Costa, P.P., Beirão, I.
core +1 more source
, 2020 Importance: Extremely preterm infants are among the populations receiving the highest levels of transfusions. Erythropoietin has not been recommended for premature infants because most studies have not demonstrated a decrease in donor exposure ...
Preterm Erythropoietin Neuroprotection Trial Consortium, +2 more
core +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
British Journal of Clinical Pharmacology, EarlyView.CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
Стандартные образцы, 2017 Analysis of the publications devoted to the structure, functions, mechanism of action of erythropoietin is given in the article. Erythropoietin preparations derived from recombinant DNA technology are a mixture of isoforms with different biological ...
A. K. Yakovlev +9 more
doaj +1 more source
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. [PDF]
PLoS ONE, 2007 The induction of tumor angiogenesis, a pathologic process critical for tumor progression, is mediated by multiple regulatory factors released by tumor and host cells.
Matthew E Hardee +8 more
doaj +1 more source